LPCAT1 and neoplasm: Prior to paclitaxel dosing, LPCAT1 led to little increase in tumor growth (Fig 5C), whereas upon paclitaxel treatment growth was more completely suppressed in control tumors than in LPCAT1 overexpressing tumors (Fig 5C).